Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ohi

Showing results (11-20 of 189) with videos related to

Pageof 19
Sort By:
Ryoikibetsu Shokogun Shirizu|January 1, 1994
[Tubercular appendicitis]H Ohi, H Nishimata
Nephron|January 1, 1990
Suppression of complement activation in hemodialysis patientsH Ohi, M Hatano
Nephron|March 30, 1999
Complement activation in cisplatin nephropathyM Tamano, H Ohi
Nephron|July 28, 2001
Decreased apolipoprotein levels are associated with decreased complement levels in acute glomerulonephritisH Ohi, M Tamano
Ryoikibetsu Shokogun Shirizu|January 1, 1997
[Renal damage with familial hyper alpha-lipoproteinemia]I Ohsawa, H Ohi
Nephron|May 4, 1999
Effects of interleukin-15 on vascular permeability factor release by peripheral blood mononuclear cells in normal subjects and in patients with minimal-change nephrotic syndromeK Matsumoto, H Ohi, K Kanmatsuse
Clinical Immunology and Immunopathology|March 1, 1992
Accelerated decay of the cell bound C4b2a complex by serum of patients with membranoproliferative glomerulonephritis and acute poststreptococcal glomerulonephritisY Tanuma, H Ohi, M Hatano
Immunology|December 1, 1989
Monoclonal anti-human C3d antibodies: stabilization of the alternative pathway C3 convertaseY Tanuma, H Ohi, M Hatano
Asia-Oceania Journal of Obstetrics and Gynaecology|September 1, 1991
Prevention by urinastatin of cis-diamminedichloroplatinum-induced nephrotoxicity in rabbits: comparison of urinary enzyme excretions and morphological alterations by electron microscopyH Kobayashi, H Ohi, T Terao
Nihon Sanka Fujinka Gakkai Zasshi|June 1, 1989
[Prevention of cisplatin induced nephrotoxicity by administering urinastatin to rabbits--comparison with other protease inhibitors]H Kobayashi, H Ohi, Y Kawashima
Pageof 19

Showing results (11-20 of 189) with videos related to

Sort By:
Pageof 19
Ryoikibetsu Shokogun Shirizu|January 1, 1994
[Tubercular appendicitis]H Ohi, H Nishimata
Nephron|January 1, 1990
Suppression of complement activation in hemodialysis patientsH Ohi, M Hatano
Nephron|March 30, 1999
Complement activation in cisplatin nephropathyM Tamano, H Ohi
Nephron|July 28, 2001
Decreased apolipoprotein levels are associated with decreased complement levels in acute glomerulonephritisH Ohi, M Tamano
Ryoikibetsu Shokogun Shirizu|January 1, 1997
[Renal damage with familial hyper alpha-lipoproteinemia]I Ohsawa, H Ohi
Nephron|May 4, 1999
Effects of interleukin-15 on vascular permeability factor release by peripheral blood mononuclear cells in normal subjects and in patients with minimal-change nephrotic syndromeK Matsumoto, H Ohi, K Kanmatsuse
Clinical Immunology and Immunopathology|March 1, 1992
Accelerated decay of the cell bound C4b2a complex by serum of patients with membranoproliferative glomerulonephritis and acute poststreptococcal glomerulonephritisY Tanuma, H Ohi, M Hatano
Immunology|December 1, 1989
Monoclonal anti-human C3d antibodies: stabilization of the alternative pathway C3 convertaseY Tanuma, H Ohi, M Hatano
Asia-Oceania Journal of Obstetrics and Gynaecology|September 1, 1991
Prevention by urinastatin of cis-diamminedichloroplatinum-induced nephrotoxicity in rabbits: comparison of urinary enzyme excretions and morphological alterations by electron microscopyH Kobayashi, H Ohi, T Terao
Nihon Sanka Fujinka Gakkai Zasshi|June 1, 1989
[Prevention of cisplatin induced nephrotoxicity by administering urinastatin to rabbits--comparison with other protease inhibitors]H Kobayashi, H Ohi, Y Kawashima
Pageof 19